Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants-Reference-Cited by-同舟云学术

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants

Published:2016-10-21 Issue:3 Volume:13 Page:588-598
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Li Yanping¹,Li Rong Cheng¹,Ye Qiang²,Li Changgui²,Liu You Ping³,Ma Xiao²,Li Yanan²,Zhao Hong³,Chen Xiaoling⁴,Assudani Deepak⁵,Karkada Naveen⁵,Han Htay Htay⁶,Van Der Meeren Olivier⁷,Mesaros Narcisa⁷

Affiliation:

1. Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning City, Guangxi, China

2. National Institutes for Food and Drug Control, Beijing, China

3. Wuzhou Center for Disease Control and Prevention, Wuzhou City, Guangxi, China

4. Mengshan Center for Disease Control and Prevention, Disease Prevention, Development District, Wuzhou City, Guangxi, China

5. GSK, Bangalore, India

6. GSK, King of Prussia, PA, USA

7. GSK, Wavre, Belgium

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy